A selective agonist for the melatonin receptors MT1 and MT2, Tasimelteon is used in the treatment of insomnia and other sleep disorders. Reference standards of Tasimelteon API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Tasimelteon
Catalogue No.:PA 47 16000
CAS :
Molecular Formula : C15H19NO2
Molecular Weight : 245.32
N-(((1S,2S)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide
Catalogue No.:PA 47 16510
N-(((1R,2S)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide
Catalogue No.:PA 47 16520
N-(((1S,2S)-2-(2,3-Dihydrobenzofuran-4-yl)-1-((2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)(propionamido)methyl)cyclopropyl)methyl)propionamide
Catalogue No.:PA 47 16530
Molecular Formula : C30H36N2O4
Molecular Weight : 488.63
2-Hydroxy-6-(2-(propionamidomethyl)cyclopropyl)phenethyl (2-(2-hydroxyethyl)-3-(2-(propionamidomethyl)cyclopropyl)phenyl) Carbonate
Catalogue No.:PA 47 16540
Molecular Formula : C31H40N2O7
Molecular Weight : 552.67
N-(((1R,2R)-2-(3-Oxo-2,3-dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide
Catalogue No.:PA 47 16550
Molecular Formula : C15H17NO3
Molecular Weight : 259.31
(1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropane-1-carboxamide
Catalogue No.:PA 47 0161000
Molecular Formula : C12H13NO2
Molecular Weight : 203.24
((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine Hydrochloride
Catalogue No.:PA 47 0161001
Molecular Formula : C12H16ClNO
Molecular Weight : 225.72
N-(((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methyl)acetamide
Catalogue No.:PA 47 0161002
Molecular Formula : C14H17NO2
Molecular Weight : 231.3
N-(((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)Cyclopropyl)methyl)Pentanamide
Catalogue No.:PA 47 0161003
Molecular Formula : C17H23NO2
Molecular Weight : 273.38
1,3-Bis(((1R,2R)-2-(2,3-Dihydro benzofuran-4-yl)cyclopropyl)methyl)urea
Catalogue No.:PA 47 0161004
Molecular Formula : C25H28N2O3
Molecular Weight : 404.51
Tasimelteon-D5
Catalogue No.:PA STI 089432
Molecular Formula : C15H14D5NO2
Molecular Weight : 250.35
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
